Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pregabalin CR vs IR in Healthy Male Volunteers
NCT02783183Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jun 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of YHD1119 in Peripheral neuropathic pain (2 arms), sponsored by Yuhan. Primary endpoints: Maximum Plasma Concentration at Steady State and Area Under the Curve over the Dosing Interval. Started Jun 2016; status: completed.
02
Drugs
YHD1119
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02783183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783183.